X-Linked Protoporphyria clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
open to eligible people ages 12-75
To investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms (burning, tingling, itching, or stinging) associated with sunlight exposure in adults and adolescents with EPP or XLP.
at UCSF
Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
Sorry, not currently recruiting here
To evaluate the long-term safety and tolerability of oral dersimelagon.
at UCSF
Last updated: